Evidence map›Paper›PMID 23544890›Full record

ArticleTissue engineering. Part A2013

Insulin, ascorbate, and glucose have a much greater influence than transferrin and selenous acid on the in vitro growth of engineered cartilage in chondrogenic media.

Alexander D Cigan, Robert J Nims, Michael B Albro, John D Esau, Marissa P Dreyer, Gordana Vunjak-Novakovic, Clark T Hung, Gerard A Ateshian

Abstract read
In one paragraph

Article in Tissue engineering. Part A, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Bioreactor Platform for Biomimetic Culture andFrontiers in bioengineering and biotechnology · 2020
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Tissue engineering. Part A · 2017
    Article
  14. Tissue engineering. Part A · 2017
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Alexander D CiganDepartment of Mechanical Engineering, Columbia University, New York, New York 10027, USA.
Robert J Nims
Michael B Albro
John D Esau
Marissa P Dreyer
Gordana Vunjak-Novakovic
Clark T Hung
Gerard A Ateshian
Columbia University · US

Funding

Craniofacial Tissue EngineeringR01DE016525 · NIDCR · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI VUNJAK-NOVAKOVIC, GORDANA · 2005 to 2017
$5.5M
PHYSIOLOGIC LOADING FOR CARTILAGE TISSUE ENGINEERINGR01AR046568 · NIAMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI HUNG, CLARK T. · 2000 to 2012
$4.9M
Optimizing Nutrient Supply in Large Engineered Cartilage Tissue ConstructsR01AR060361 · NIAMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ATESHIAN, GERARD A., HUNG, CLARK T. · 2010 to 2014
$1.7M
Multidisciplinary Engineering Training in Musculoskeletal ResearchT32AR059038 · NIAMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ATESHIAN, GERARD A. · 2011 to 2015
$1.3M
NIAMS NIH HHS R01 AR046568NIAMS NIH HHS R01AR046568NIAMS NIH HHS R01 AR060361NIAMS NIH HHS R01AR060361NIAMS NIH HHS T32 AR059038NIAMS NIH HHS T32AR059038NIDCR NIH HHS R01 DE016525
6 · The paper itself

Abstract

The primary goal of this study was to characterize the response of chondrocyte-seeded agarose constructs to varying concentrations of several key nutrients in a chondrogenic medium, within the overall context of optimizing the key nutrients and the placement of nutrient channels for successful growth of cartilage tissue constructs large enough to be clinically relevant in the treatment of osteoarthritis (OA). To this end, chondrocyte-agarose constructs (ø4×2.34 mm, 30×10(6) cells/mL) were subjected to varying supplementation levels of insulin (0× to 30× relative to standard supplementation), transferrin (0× to 30×), selenous acid (0× to 10×), ascorbate (0× to 30×), and glucose (0× to 3×). The quality of resulting engineered tissue constructs was evaluated by their compressive modulus (E(-Y)), tensile modulus (E(+Y)), hydraulic permeability (k), and content of sulfated glycosaminoglycans (sGAG) and collagen (COL); DNA content was also quantified. Three control groups from two separate castings of constructs (1× concentrations of all medium constituents) were used. After 42 days of culture, values in each of these controls were, respectively, E(-Y)=518±78, 401±113, 236±67 kPa; E(+Y)=1420±430, 1140±490, 1240±280 kPa; k=2.3±0.8×10(-3), 5.4±7.0×10(-3), 3.3±1.3×10(-3) mm(4)/N·s; sGAG=7.8±0.3, 6.3±0.4, 4.1±0.5%/ww; COL=1.3±0.2, 1.1±0.3, 1.4±0.4%/ww; and DNA=11.5±2.2, 12.1±0.6, 5.2±2.8 μg/disk. The presence of insulin and ascorbate was essential, but their concentrations may drop as low as 0.3× without detrimental effects on any of the measured properties; excessive supplementation of ascorbate (up to 30×) was detrimental to E(-Y), and 30× insulin was detrimental to both E(+Y) and E(-Y). The presence of glucose was similarly essential, and matrix elaboration was significantly dependent on its concentration (p<10(-6)), with loss of functional properties, composition, and cellularity observed at ≤0.3×; excessive glucose supplementation (up to 3×) showed no detrimental effects. In contrast, transferrin and selenous acid had no influence on matrix elaboration. These findings suggest that adequate distributions of insulin, ascorbate, and glucose, but not necessarily of transferrin and selenous acid, must be ensured within large engineered cartilage constructs to produce a viable substitute for joint tissue lost due to OA.

Indexed as

AnimalsAscorbic AcidCartilageCattleCells, CulturedChondrocytesChondrogenesisFemaleGlucoseInsulinMaleSelenious AcidTissue EngineeringTransferrinAscorbic AcidGlucoseInsulinSelenious AcidTransferrin

Identifiers

PMID23544890
PMCPMC3725793
OpenAlexW2000697736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.